Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019

NEXT STORY
Global Next-generation Sequencing (NGS) Market Outlook and Forecast Report 2019-2025 – NGS Data Analysis Using Big Data Presents Lucrative Industry Opportunities
PREV STORY
PCI Biotech to present Phase I fimaVacc results at ESMO Immuno-Oncology 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Codiak BioSciences Appoints Anne-Virginie Eggimann, M.Sc., to Board of Directors

author_avatar
NASDAQ Market News

Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies

- Pivotal AdAPT Study of Oral Brincidofovir for Adenovirus Now Enrolling -  - No ...

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form

BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News